Next, we have performed bioinformatics analysis for our collected NPC specimens, which show that NPC patients with high HBP1 expression have a higher TNM stage (TNM III-IV) than those with low HBP1 expression (TNM I-II) (Table 1). This evidence concerns the gene HBP1 and nasopharyngeal carcinoma.